Advertisement
Advertisement

TAK

TAK logo

Takeda Pharmaceutical Company Limited - ADR

16.55
USD
Sponsored
-0.06
-0.39%
Jul 10, 12:28 UTC -4
Open

TAK Earnings Reports

Positive Surprise Ratio

TAK beat 28 of 40 last estimates.

70%

Next Report

Date of Next Report
Jul 28, 2026
Estimate for Q1 27 (Revenue/ EPS)
$1.17T
/
$53.05
Implied change from Q4 26 (Revenue/ EPS)
+6.48%
/
-440.94%
Implied change from Q1 26 (Revenue/ EPS)
+5.31%
/
-33.19%

Takeda Pharmaceutical Company Limited - ADR earnings per share and revenue

On May 13, 2026, TAK reported earnings of -15.56 USD per share (EPS) for Q4 26, beating the estimate of -24.25 USD, resulting in a 35.85% surprise. Revenue reached 1.09 trillion, compared to an expected 1.13 trillion, with a -3.31% difference. The market reacted with a +1.34% price change (close before vs. close after earnings).
Looking ahead to Q1 27, 3 analysts forecast an EPS of 53.05 USD, with revenue projected to reach 1.17 trillion USD, implying an decrease of -440.94% EPS, and increase of 6.48% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Cybin Inc. Common Stock
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.91
Actual
-$1.16
Surprise
-27.08%
FAQ
For Q4 2026, Takeda Pharmaceutical Company Limited - ADR reported EPS of -$15.56, beating estimates by 35.85%, and revenue of $1.09T, -3.31% below expectations.
The stock price moved up 1.34%, changed from $16.42 before the earnings release to $16.64 the day after.
The next earning report is scheduled for Jul 28, 2026.
Based on 3 analysts, Takeda Pharmaceutical Company Limited - ADR is expected to report EPS of $53.05 and revenue of $1.17T for Q1 2027.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement